eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

UCB Pharma Limited
208 Bath Road, Slough, Berkshire, SL1 3WE
Telephone: +44 (0)1753 534 655
Medical Information Direct Line: +44 (0)1753 447 690
Medical Information e-mail: Medicalinformationuk@ucb.com
Customer Care direct line: +44 (0) 1773 510123

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 03/10/2011
PIL Keppra 250mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/10/2011 and displayed until Current
Reasons for adding or updating:
  • Unknown
Updated on 08/09/2010 and displayed until 03/10/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/09/2010 and displayed until 08/09/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 21/01/2010 and displayed until 07/09/2010
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 19/02/2009 and displayed until 21/01/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 08/11/2007 and displayed until 19/02/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 06/03/2007 and displayed until 08/11/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Changes to therapeutic indications
  • Change to date of revision
Updated on 06/03/2007 and displayed until 06/03/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to warnings or special precautions for use
  • PIL Submitted in error
Updated on 19/04/2006 and displayed until 06/03/2007
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 02/04/2004 and displayed until 19/04/2006
Reasons for adding or updating:
  • Change to date of revision
Updated on 20/08/2002 and displayed until 02/04/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  levetiracetam